SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain training program aims to help seniors with schizophrenia live more independently
Disease control OngoingThis study is testing whether combining two types of therapy can help older adults with schizophrenia improve their daily functioning. The program blends cognitive-behavioral social skills training with computerized brain exercises designed to boost thinking skills. Researchers a…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Cash for shots: can paying patients stop costly mental health crises?
Disease control ENROLLING_BY_INVITATIONThis study is testing if offering small financial rewards can help people with serious mental health conditions take their long-acting injectable medications more consistently. It involves 1000 people in Pennsylvania with schizophrenia, bipolar disorder, or similar conditions who…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Brain training trial aims to boost recovery for young adults with psychosis
Disease control TerminatedThis study is testing whether adding a brain skills training program, called cognitive remediation, to standard early psychosis care helps young adults function better in work, school, and social life. It will compare two ways of delivering the training: fully in-person with a cl…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Quick-Dissolve film tested to calm psychiatric crises in ER
Symptom relief TerminatedThis study aimed to test a medication called BXCL501, a small dissolving film placed under the tongue, for quickly calming severe agitation in adults with bipolar disorder or schizophrenia arriving at the emergency department. The goal was to see how well and safely it worked in …
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Virtual reality headsets tested as new tool for schizophrenia therapy
Symptom relief OngoingThis small pilot study is testing whether using immersive virtual reality (VR) headsets is a safe and practical way to help people with schizophrenia or schizoaffective disorder. It aims to see if practicing tasks in realistic VR simulations can improve thinking skills, reduce ce…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco • Aim: Symptom relief
Last updated Mar 16, 2026 15:27 UTC
-
Researchers seek better way to gauge mental health crises
Knowledge-focused OngoingThis study aims to see if questionnaires filled out by patients and their close contacts (like family members) during episodes of severe agitation match up with ratings from doctors. It involves about 30 adults with schizophrenia or bipolar disorder and their chosen informant. Th…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE2 • Sponsor: BioXcel Therapeutics Inc • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC